<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:opensearch="http://a9.com/-/spec/opensearch/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/">
  <channel>
    <title>Results for Pergolesi, Federica</title>
    <description>Showing 1 - 3 results of 3</description>
    <generator>Laminas_Feed_Writer 2 (https://getlaminas.org)</generator>
    <link>https://buscaintegrada.ufrj.br/Author/?sort=last_indexed+desc&amp;limit=50&amp;author=%22Pergolesi%2C+Federica%22&amp;type=Author</link>
    <opensearch:totalResults>3</opensearch:totalResults>
    <opensearch:startIndex>0</opensearch:startIndex>
    <opensearch:itemsPerPage>50</opensearch:itemsPerPage>
    <opensearch:Query role="request" searchTerms="%22Pergolesi%2C%20Federica%22" startIndex="0"/>
    <atom:link rel="first" type="application/rss+xml" href="https://buscaintegrada.ufrj.br/Author/?sort=last_indexed+desc&amp;limit=50&amp;view=rss&amp;author=%22Pergolesi%2C+Federica%22&amp;type=Author"/>
    <atom:link rel="last" type="application/rss+xml" href="https://buscaintegrada.ufrj.br/Author/?sort=last_indexed+desc&amp;limit=50&amp;view=rss&amp;author=%22Pergolesi%2C+Federica%22&amp;type=Author"/>
    <atom:link rel="self" type="application/rss+xml" href="https://buscaintegrada.ufrj.br/Author/?sort=last_indexed+desc&amp;limit=50&amp;view=rss&amp;author=%22Pergolesi%2C+Federica%22&amp;type=Author"/>
    <item>
      <title>A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable</title>
      <pubDate>Tue, 01 Jan 2019 06:03:28 -0200</pubDate>
      <link>https://buscaintegrada.ufrj.br/Record/pubmed-6391761</link>
      <guid>https://buscaintegrada.ufrj.br/Record/pubmed-6391761</guid>
      <author>Cortellini, Alessio</author>
      <dc:format>Artigo</dc:format>
      <dc:date>2019</dc:date>
      <dc:creator>Cortellini, Alessio</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Early fatigue in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: an insight from clinical practice</title>
      <pubDate>Tue, 01 Jan 2019 06:03:28 -0200</pubDate>
      <link>https://buscaintegrada.ufrj.br/Record/pubmed-6857130</link>
      <guid>https://buscaintegrada.ufrj.br/Record/pubmed-6857130</guid>
      <author>Cortellini, Alessio</author>
      <dc:format>Artigo</dc:format>
      <dc:date>2019</dc:date>
      <dc:creator>Cortellini, Alessio</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: the multicenter FAMI-L1 study</title>
      <pubDate>Wed, 01 Jan 2020 06:03:28 -0300</pubDate>
      <link>https://buscaintegrada.ufrj.br/Record/pubmed-6959456</link>
      <guid>https://buscaintegrada.ufrj.br/Record/pubmed-6959456</guid>
      <author>Cortellini, Alessio</author>
      <dc:format>Artigo</dc:format>
      <dc:date>2020</dc:date>
      <dc:creator>Cortellini, Alessio</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
  </channel>
</rss>
